Liquidia Corp (LQDA)
10.46
-0.52
(-4.74%)
USD |
NASDAQ |
Nov 04, 16:00
10.50
+0.04
(+0.38%)
After-Hours: 20:00
Liquidia Enterprise Value: 749.50M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 749.50M |
| November 01, 2024 | 793.38M |
| October 31, 2024 | 782.41M |
| October 30, 2024 | 795.91M |
| October 29, 2024 | 798.44M |
| October 28, 2024 | 797.60M |
| October 25, 2024 | 795.91M |
| October 24, 2024 | 799.28M |
| October 23, 2024 | 801.82M |
| October 22, 2024 | 811.94M |
| October 21, 2024 | 802.66M |
| October 18, 2024 | 806.88M |
| October 17, 2024 | 833.88M |
| October 16, 2024 | 848.22M |
| October 15, 2024 | 827.13M |
| October 14, 2024 | 806.46M |
| October 11, 2024 | 802.24M |
| October 10, 2024 | 798.44M |
| October 09, 2024 | 803.50M |
| October 08, 2024 | 796.75M |
| October 07, 2024 | 807.72M |
| October 04, 2024 | 713.22M |
| October 03, 2024 | 718.28M |
| October 02, 2024 | 711.11M |
| October 01, 2024 | 729.25M |
| Date | Value |
|---|---|
| September 30, 2024 | 710.69M |
| September 27, 2024 | 711.53M |
| September 26, 2024 | 722.50M |
| September 25, 2024 | 736.84M |
| September 24, 2024 | 720.81M |
| September 23, 2024 | 704.78M |
| September 20, 2024 | 706.47M |
| September 19, 2024 | 733.47M |
| September 18, 2024 | 703.09M |
| September 17, 2024 | 692.12M |
| September 16, 2024 | 710.69M |
| September 13, 2024 | 693.39M |
| September 12, 2024 | 687.06M |
| September 11, 2024 | 646.75M |
| September 10, 2024 | 550.37M |
| September 09, 2024 | 574.18M |
| September 06, 2024 | 565.35M |
| September 05, 2024 | 561.89M |
| September 04, 2024 | 553.44M |
| September 03, 2024 | 565.73M |
| August 30, 2024 | 597.22M |
| August 29, 2024 | 599.52M |
| August 28, 2024 | 599.52M |
| August 27, 2024 | 607.97M |
| August 26, 2024 | 621.79M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
33.83M
Minimum
Dec 19 2019
1.188B
Maximum
Mar 22 2024
326.26M
Average
259.32M
Median
Jan 12 2022
Enterprise Value Benchmarks
| United Therapeutics Corp | 13.90B |
| Arcturus Therapeutics Holdings Inc | 221.56M |
| Paragon 28 Inc | 570.08M |
| Tonix Pharmaceuticals Holding Corp | 7.452M |
| AIM ImmunoTech Inc | 8.843M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -27.94M |
| Revenue (Quarterly) | 3.659M |
| Total Expenses (Quarterly) | 30.86M |
| EPS Diluted (Quarterly) | -0.37 |
| Gross Profit Margin (Quarterly) | 59.20% |
| Profit Margin (Quarterly) | -763.7% |
| Earnings Yield | -15.01% |
| Normalized Earnings Yield | -13.55 |